RNA-based vaccines can broaden the arsenal of vaccine strategies in the veterinary space
While various vaccine strategies have been developed over time, each comes with limitation.
RNA vaccines stand out as the only approach rated excellent across all key dimensions. This makes them a transformative option in the veterinary space, combining scientific performance with practical deployment advantages.
Beyond mRNA, saRNA further increase vaccines affordability and efficacy
saRNA facilitates robust antigen expression at lower doses thanks to the self-replicating properties, thereby enhancing both immunogenicity and cost-effectiveness
BENEFITS
- Enables RNA self-amplification, reducing required dose.
- Potential for durable immunity.
- Allows rapid, cell-free, and scalable production (good for pandemic response).
- Increases vaccine yield from each manufacturing batch.
- Enhances delivery efficiency and protects RNA from degradation.
We empower you to unlock the full potential of RNA innovation through diverse collaboration opportunities
A challenge study in 70 chickens using a currently circulating H5N1 strain demonstrated 100% survival in all vaccinated animals, even at the lowest dose, with no viral transmission observed, as evidenced by the absence of shedding. The saRNA mosaic vaccine candidate was fully designed, produced, and formulated by Quantoom.
In vivo validation of our N-Force toolbox
Quantoom has collaborated with top-tier partners and renowned research institutions to evaluate and validate the use of its toolbox in multiple target-species studies.
Bioinformatics expertise for RNA bioprocessing
Advanced bioinformatics to enhance expression, stability, and manufacturability
Our platform goes beyond standard codon optimization, enabling seamless transition from antigen design to fully optimized RNA-based modalities. With our technology-driven approach, we help accelerate the path from concept to scalable mRNA production.
Quantoom is revolutionizing the RNA encapsulation with its proprietary delivery chemistries
We offer a library of delivery chemistries with demonstrated performances in in-vivo and target species. Compared to gold-standard solution, our chemistries increase total protein expression. They are available as various offering depending on your specific needs; from raw material to custom services.
Unlocking Ultra-Low Cost RNA Vaccines
With a 20g of DP/batch, Quantoom is removing the cost barriers by providing a solution allowing to go as low as 2.5$ for 1,000 doses
Based on promising results, we can confirm that saRNA is the solution for Animal Health as it enables to remove the cost barriers associated with RNA vaccines. The target total cost of manufacturing (i.e., by Quantoom’stechnology) shows price range similar of existing low-cost vaccines.
Ntensify midi system allows rapid transfer to commercial production
We empower you to unlock the full potential of RNA innovation through diverse collaboration opportunities
We put our N-force into motion for/with our partners allowing to accelerate the translation of your science and research into life-changing (sa)mRNA medicines.
Discover our recent webinar!
“Reinventing RNA for Animal Health: an end-to-end solution to fast track your way to RNA veterinary vaccines”
Discover how self-amplifying RNA (saRNA) is transforming animal vaccine development. In this webinar, we’ll explore Quantoom’s N-Force toolbox through two case studies—rabies and avian influenza—showcasing how our scalable saRNA platform enables high-quality, low-cost RNA vaccine production. From molecular design to formulation, learn how we help accelerate the path to effective veterinary vaccines.
Fill in the form on the right to access the webinar →